SNDX Historical Earnings image   This SNDX historical earnings page last updated 11/7/2022
SNDX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022NA
Q2 20228/8/2022NA
Q1 20225/9/2022NA
Q4 20213/1/20220.13B
Q3 202111/15/20210.01B
Q2 20218/9/20210.00B
Q1 20215/11/20210.00B
Q4 20203/8/20210.00B
Q3 202011/2/20200.00B
Q2 20208/6/20200.00B
Q1 20205/7/20200.00B
Q4 20193/3/20200.00B
Q3 201911/7/20190.00B
Q2 20198/7/20190.00B
Q1 20195/6/20190.00B
Q4 20183/7/2019380000
Q3 201811/5/2018379000
Q2 20188/7/2018379000
Q1 20185/8/2018379000
Q4 20173/5/20181.19M
Q3 201711/7/2017305000
Q2 20178/10/2017305000
Q1 20175/8/2017305000
Q4 20163/2/2017305000
Q3 201611/10/2016305000
Q2 20168/9/2016305000
Q1 20165/16/2016305000
SNDX Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022-0.580
Q2 20228/8/2022-0.620
Q1 20225/9/2022-0.630
Q4 20213/1/20221.810
Q3 202111/15/2021-0.400
Q2 20218/9/2021-0.440
Q1 20215/11/2021-0.540
Q4 20203/8/2021-0.440
Q3 202011/2/2020-0.460
Q2 20208/6/2020-0.420
Q1 20205/7/2020-0.560
Q4 20193/3/2020-0.440
Q3 201911/7/2019-0.410
Q2 20198/7/2019-0.470
Q1 20195/6/2019-0.530
Q4 20183/7/2019-0.7
Q3 201811/5/2018-0.68
Q2 20188/7/2018-0.74
Q1 20185/8/2018-0.79
Q4 20173/5/2018-0.8
Q3 201711/7/2017-0.68
Q2 20178/10/2017-0.7
Q1 20175/8/2017-0.71
Q4 20163/2/2017-0.59
Q3 201611/10/2016-0.84
Q2 20168/9/2016-0.47
Q1 20165/16/2016-2.85
Quotes delayed 20 minutes

Email EnvelopeFree SNDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Syndax Pharmaceuticals (SNDX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SNGX Historical Earnings
SNOA Historical Earnings
SNPX Historical Earnings
SNSE Historical Earnings
SOLY Historical Earnings
SONN Historical Earnings
SPNE Historical Earnings
SPPI Historical Earnings
SPRB Historical Earnings
SPRO Historical Earnings
What was the record high SNDX historical earnings result?
In terms of earnings or revenue, what is the best SNDX historical earnings result that Syndax Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SNDX historical earnings result was set in Q4 2021, when Syndax Pharmaceuticals posted results of 1.810/share. The most successful revenue quarter within our data set was Q4 2021 when Syndax Pharmaceuticals reported revenue of 0.13B.

What was the lowest Syndax Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SNDX has reported, and when?

✔️Accepted answer: Within our data set, the lowest SNDX historical earnings result was set in Q1 2016, when Syndax Pharmaceuticals posted results of -2.85/share. The smallest revenue quarter within our data set was Q3 2022 when Syndax Pharmaceuticals reported revenue of NA.

On this page we presented the SNDX historical earnings date information for Syndax Pharmaceuticals. Reviewing that SNDX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2021, when SNDX posted gaap of 1.810/share. Meanwhile the lowest SNDX historical earnings result was in Q1 2016, when SNDX posted gaap of -2.85/share. Moving to Syndax Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when SNDX reported 0.13B in revenue, while the smallest revenue quarter was Q3 2022 when SNDX reported NA in revenue.

For self directed investors doing their due diligence on SNDX or any other given stock, their research can benefit from looking into all of the Syndax Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Syndax Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SNDX. Thanks for visiting, and the next time you need to research SNDX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: ASPS Videos, MLPA shares outstanding history, BBBY shares outstanding history.

 

SNDX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.